One of the DTFs, GATA3, may play a crucial role in ccRCC, as it can potentially regulate all three biologic alterations identified in ccRCC: loss of renal epithelial differentiation, adipogenic differentiation, and immune activation. The gene discussed is GATA3; the disease is nonpapillary renal cell carcinoma.